Authorized representative profileFukushima Medical Equipment Co., Ltd
Taiwan新北市鶯歌區國慶街26號12 products representedSep 20, 2005 – Aug 08, 2011
VerifiedTFDA · Taiwan Food and Drug Administration registry
12
Products represented
3
Manufacturers
0
Active products
Aug 2011
Latest registration
Company details
- Address
- 新北市鶯歌區國慶街26號
- Authorization Code
- 16511892.0
Regulatory footprint
Search Fukushima Medical Equipment Co., Ltd across other regulatory registries
Thailand
European Union
Colombia
South Korea
Canada
EcuadorRecent registrations
Latest 5 products represented by this organization
Fukushima mild oxygen pressurized chamber
Class 2
Aug 08, 2011
Fukushima Rapid Prostate-Specific Antigen Assay Reagent
Class 2
Apr 19, 2006
Fukushima Rapid Measure of Metaglobin
Class 2
Apr 19, 2006
Fukushima Quick Fetch A Fetal Globulin Rapid Assay Reagent
Class 2
Apr 19, 2006
Fukushima rapid reagent cartridge reader
Class 1
Mar 16, 2006
Most popular products
Products with most registrations
Fukushima mild oxygen pressurized chamber
1 registrations
Fukushima Rapid Prostate-Specific Antigen Assay Reagent
1 registrations
Fukushima Rapid Measure of Metaglobin
1 registrations
Fukushima Quick Fetch A Fetal Globulin Rapid Assay Reagent
1 registrations
Fukushima rapid reagent cartridge reader
1 registrations
Represented manufacturers
Manufacturers whose products are represented by this organization
Recent represented products
Most recent products (showing top 20)
Fukushima mild oxygen pressurized chamber
Registered: Aug 08, 2011 • Expires: Aug 08, 2016
Cancelled
- Risk Class
- Class 2
- Manufacturer
- MEDICONET CO., LTD.
Fukushima Rapid Prostate-Specific Antigen Assay Reagent
Registered: Apr 19, 2006 • Expires: Apr 19, 2011
Cancelled
- Risk Class
- Class 2
- Manufacturer
- VEDA LAB
Fukushima Rapid Measure of Metaglobin
Registered: Apr 19, 2006 • Expires: Apr 19, 2011
Cancelled
- Risk Class
- Class 2
- Manufacturer
- VEDA LAB
Fukushima Quick Fetch A Fetal Globulin Rapid Assay Reagent
Registered: Apr 19, 2006 • Expires: Apr 19, 2011
Cancelled
- Risk Class
- Class 2
- Manufacturer
- VEDA LAB
Fukushima rapid reagent cartridge reader
Registered: Mar 16, 2006 • Expires: Mar 16, 2016
Cancelled
- Risk Class
- Class 1
- Manufacturer
- VEDA LAB
Fukushima Chlamydomydia rapid immunochromatography assay
Registered: Dec 22, 2005 • Expires: Dec 22, 2010
Cancelled
- Risk Class
- Class 1
- Manufacturer
- VEDA LAB
Fukushima Quick-take Streptococcus B Rapid Assay Reagent
Registered: Dec 22, 2005 • Expires: Dec 22, 2010
Cancelled
- Risk Class
- Class 1
- Manufacturer
- VEDA LAB
Fukushima Kotake pylori rapid assay reagent
Registered: Dec 22, 2005 • Expires: Dec 22, 2010
Cancelled
- Risk Class
- Class 1
- Manufacturer
- VEDA LAB
Fukushima decisive cardiac marker 3-in-1 rapid assay reagent
Registered: Oct 03, 2005 • Expires: Oct 03, 2010
Cancelled
- Manufacturer
- SPECTRAL DIAGNOSTICS INC.
Fukushima Decisive Myocardial Rotation Protein I Rapid Assay Reagent
Registered: Sep 26, 2005 • Expires: Sep 26, 2010
Cancelled
- Manufacturer
- SPECTRAL DIAGNOSTICS INC.
Fukushima endotoxin activity analysis reagent
Registered: Sep 20, 2005 • Expires: Sep 20, 2010
Cancelled
- Manufacturer
- SPECTRAL DIAGNOSTICS INC.
Fukushima Snap Myocardial Rotation Protein│ Rapid Assay Reagent
Registered: Sep 20, 2005 • Expires: Sep 20, 2015
Cancelled
- Risk Class
- Class 2
- Manufacturer
- VEDA LAB
About this profile
Explore comprehensive authorized representative profile for Fukushima Medical Equipment Co., Ltd through Pure Global AI's free Taiwan medical device database. This authorized representative handles 12 product registrations across 3 manufacturers and 12 unique product types. Their regulatory history spans from Sep 20, 2005 to Aug 08, 2011.
This page provides detailed insights including 5 recent product registrations, 5 most popular products with Fukushima mild oxygen pressurized chamber having 1 registrations, and 3 represented manufacturers including VEDA LAB. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.